Document is current

Article History

Received: 4 April 2023

Accepted: 31 May 2023

First Online: 1 July 2023

Declarations

:

: This narrative article contains no original data and thus issues of ethics, informed consent and patient confidentiality do not apply.

: J.Y.R. has received fees for lectures or advisory boards from IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Faes Pharma, Rejuvinate Biomed, Teva, Theramex, Pfizer, Mithra Pharmaceuticals, CNIEL, Dairy Research Council, Nutricia, Danone and Agnovos, and industry grants (all through institution) from IBSA-Genevrier, Mylan, CNIEL, Radius Health and TRB, outside the submitted work.C.C. reports personal fees from ABBH, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier and Takeda, outside the submitted work.N.C.H. reports personal fees, consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, UCB, Kyowa Kirin, Servier, Shire, Theramex, Consilient Healthcare and Internis Pharma, outside the submitted work.L.K. reports lecture fees and honoraria from Alexion, Amgen, Ascendis, Medimaps (2 single presentations), and Radius, outside the submitted work.E.V.M reports consultancy, advisory boards and or lecture fees from Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, GSK, Hologic, Internis, Lilly, ObsEva, Pfizer, UCB. Additional research support from Versus Arthritis, I3 Innovus, MRC and IOF.N.V. reports personal fees from IBSA, Mylan, Viatris, Fidia, MSD outside of the submitted work.N.A-D., D.M.C., M.C., A-L.D., O.L., D.M., J.P., M-P.L., S.T. declare no conflicts of interest.